Document text
Principal Investigator: Michael Michaelides
Organization: NATIONAL INSTITUTE ON DRUG ABUSE
Fiscal Year: 2021
Award: $1,630,210
Funding agency: National Institute on Drug Abuse
The societal and economic burden of substance use disorders is vast and ever-increasing. To address this requires developing innovative therapeutics, an approach necessitating a deep understanding of behavior and its neurobiological basis. Fortunately, the last decade has witnessed a surge of breakthrough technologies with significant promise for advancing the understanding of the neurobiological basis of normal and pathological behavior. Our goal is to leverage the unique NIH intramural environment to establish a pioneering, and collaborative, translational research program. This program will implement state-of-the-art biobehavioral molecular imaging approaches integrated alongside cutting-edge neuromodulatory (e.g. chemogenetic, optogenetic), molecular, pharmacological, transgenic, and bioinformatic methods for identifying behaviorally-relevant neurobiological mechanisms associated with substance use disorders and related comorbid diseases/disorders. Special emphasis will be placed on reverse-translating findings from clinical research to animals. In addition, clinical relevance of mechanisms studied in animals will be determined in humans via bioinformatic, genetic and postmortem tissue examination.
One of the labs core areas of focus will be on development and application of novel molecular imaging strategies for assessment of whole-brain and cellular-level molecular dynamics simultaneously with behavior in animal models of substance use disorders. Another major core focus involves development of novel theranostic neuromodulation technologies that can be used for clinical treatment of addiction and other disease states.
Terms: <2019-nCoV S protein><2019-nCoV spike glycoprotein><2019-nCoV spike protein><Address><Animal Model><Animal Models and Related Studies><Animals><Area><Autopsy><Behavior><Behavioral><Bio-Informatics><Bioinformatics><Body Tissues><Brain><Brain Nervous System><COVID-19 S protein><COVID-19 spike glycoprotein><COVID-19 spike protein><COVID19 S protein><COVID19 spike glycoprotein><COVID19 spike protein><Clinical Research><Clinical Study><Clinical Treatment><Development><Disease><Disorder><Drug Therapy><Economic Burden><Encephalon><Environment><Genetic><Goals><Human><Image><Imaging technology><Ketamine><Metabolic><Methods><Modern Man><Molecular><Molecular Dynamics Simulation><Molecular Neurobiology><NIH><National Institutes of Health><Neurobiology><Pathologic><Peripheral><Pharmacology><Pharmacotherapy><Proteins><Psychological reinforcement><Reinforcement><Role><SARS-CoV-2 S protein><SARS-CoV-2 spike glycoprotein><SARS-CoV-2 spike protein><SARS-CoV2 S protein><SARS-CoV2 spike glycoprotein><SARS-CoV2 spike protein><Severe acute respiratory syndrome coronavirus 2 S protein><Severe acute respiratory syndrome coronavirus 2 spike glycoprotein><Severe acute respiratory syndrome coronavirus 2 spike protein><Substance Use Disorder><Substance abuse problem><Synapses><Synaptic><System><Technology><Therapeutic><Tissues><Transgenic Organisms><Translating><Translational Research Enterprise><United States National Institutes of Health><Zinc><Zn element><abuse of substances><addiction><addictive disorder><biobehavior><biobehavioral><clinical relevance><clinically relevant><co-morbid><co-morbidity><comorbidity><coronavirus disease 2019 S protein><coronavirus disease 2019 spike glycoprotein><coronavirus disease 2019 spike protein><developmental><drug treatment><image-based method><imaging><imaging approach><imaging based approach><imaging method><imaging modality><in vivo><innovate><innovation><innovative><model of animal><model organism><molecular dynamics><molecular imaging><molecule imaging><necropsy><neural control><neural regulation><neurobiological><neurobiological mechanism><neuromodulation><neuromodulatory><neuropsychopharmacology><neuroregulation><novel><optic imaging><optical imaging><optogenetics><postmortem><programs><social role><substance abuse><synapse><theranostics><transgenic><translation research enterprise><translational research program><trial regimen><trial treatment>